92932-75-7 Usage
Molecular structure
2-(3-sulfanylpropanoyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid consists of a sulfanylpropanoyl group and a tetrahydroisoquinoline-1-carboxylic acid group.
Potential pharmaceutical applications
The complex structure of the molecule suggests that it may have potential uses in medicine due to its ability to interact with biological systems.
Antioxidant properties
The presence of the sulfanyl group in the molecule indicates that it may possess antioxidant properties, which could be beneficial in various medical applications.
Bioactive compounds
The tetrahydroisoquinoline core is commonly found in bioactive compounds, such as alkaloids, which are known for their pharmacological effects.
Further research and analysis
To gain a better understanding of the potential uses and applications of 2-(3-sulfanylpropanoyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, additional research and analysis are required to explore its properties and interactions with biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 92932-75-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,9,3 and 2 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 92932-75:
(7*9)+(6*2)+(5*9)+(4*3)+(3*2)+(2*7)+(1*5)=157
157 % 10 = 7
So 92932-75-7 is a valid CAS Registry Number.
92932-75-7Relevant academic research and scientific papers
2-(3-Mercapto-1-oxopropyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid derivatives
-
, (2008/06/13)
Compounds of the formula: STR1 wherein R is H or STR2 and n is 0 or 1 are useful as angiotensin I converting enzyme inhibitors.
Angiotensin converting enzyme inhibitors: N-substituted monocyclic and bicyclic amino acid derivatives
Stanton,Gruenfeld,Babiarz,Ackerman,Friedmann,Yuan,Macchia
, p. 1267 - 1277 (2007/10/02)
The synthesis of N-(3-mercaptopropionyl)-N-arylglycines (14a-x), -N-arylalanines (15a,b), -N-cycloalkylglycines (16a-k), and -1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids (17a-d), -1,2,3,4-tetrahydroquinoline-2-carboxylic acids (18a-f), and -indoline-2-carboxylic acids (19a-k) is described. In vitro inhibition of angiotensin converting enzyme (ACE) is reported for each compound, and the structure-activity relationship for each series is discussed. The in vivo inhibition of ACE and antihypertensive effects of representative compounds from each series are discussed. The most potent compound, 19d, had an in vitro ACE IC50 of 2.6 x 10-9 M and lowered blood pressure in spontaneous hypertensive rats 85 mm at a dose of 10 mg/kg po.
